Cargando…

A Systematic Review and Meta-Analysis of the Efficacy of Anti-Toxoplasma gondii Medicines in Humans

No effective drug and definitive “gold standard” treatment for Toxoplasma gondii (T. gondii) infection has been available so far, though some medicines have been commonly used in the treatment of T. gondii infection, such as spiramycin, azithromycin, traditional Chinese medicine (TCM), pyrimethamine...

Descripción completa

Detalles Bibliográficos
Autores principales: Wei, Hai-Xia, Wei, Shan-Shan, Lindsay, David S., Peng, Hong-Juan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4578932/
https://www.ncbi.nlm.nih.gov/pubmed/26394212
http://dx.doi.org/10.1371/journal.pone.0138204
_version_ 1782391189623799808
author Wei, Hai-Xia
Wei, Shan-Shan
Lindsay, David S.
Peng, Hong-Juan
author_facet Wei, Hai-Xia
Wei, Shan-Shan
Lindsay, David S.
Peng, Hong-Juan
author_sort Wei, Hai-Xia
collection PubMed
description No effective drug and definitive “gold standard” treatment for Toxoplasma gondii (T. gondii) infection has been available so far, though some medicines have been commonly used in the treatment of T. gondii infection, such as spiramycin, azithromycin, traditional Chinese medicine (TCM), pyrimethamine- sulfadiazine (P-S), trimethoprim-sulfamethoxazole (TMP-SMX), and pyrimethamine-clindamycin (P-C). A systematic review and meta-analysis were performed to compare the efficacies of these conventional medicines in the treatment. Cohort studies for the treatment of acute T. gondii infection were searched from PubMed, Google Scholar, ect. All the cases number for different group extracted from each included literature were input to meta-analysis 3.13 software to calculate the pooled negative conversion rate (NCR), cure rate (CR) or vertical transmission rate based on their sample size and weight. The pooled NCR with 95% confidence intervals (CI) was used to evaluate the overall rate of a diagnosis positive result conversion to a negative result after treatment, which of spiramycin, azithromycin and TCM were 83.4% (95%CI, 72.1%-90.8%), 82.5% (95%CI, 75.9%-87.6%), and 85.5% (95%CI, 71.3%-93.3%) respectively, with no statistical difference between them. The pooled CR with 95% CI was used to evaluate the overall rate of complete disappearance of clinical symptoms for toxoplasmic encephalitis after therapy, which of P-S, TMP-SMX, and P-C were 49.8% (95%CI, 38. 8% -60.8%), 59.9% (95%CI, 48.9%-70.0%), and 47.6% (95%CI, 24.8%-71.4%) respectively, with no statistical difference between them. Primary T. gondii infection in pregnancy was treated mainly with spiramycin alone or combined with other drugs, and the pooled rate of vertical transmission was about 9.9% (95%CI, 5.9%-16.2%) after therapy. Toxoplasmic encephalitis in AIDS patients was usually treated with sulfonamides combined with other drugs and the pooled CR was 49.4% (95%CI, 37.9%-60.9%).
format Online
Article
Text
id pubmed-4578932
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-45789322015-10-01 A Systematic Review and Meta-Analysis of the Efficacy of Anti-Toxoplasma gondii Medicines in Humans Wei, Hai-Xia Wei, Shan-Shan Lindsay, David S. Peng, Hong-Juan PLoS One Research Article No effective drug and definitive “gold standard” treatment for Toxoplasma gondii (T. gondii) infection has been available so far, though some medicines have been commonly used in the treatment of T. gondii infection, such as spiramycin, azithromycin, traditional Chinese medicine (TCM), pyrimethamine- sulfadiazine (P-S), trimethoprim-sulfamethoxazole (TMP-SMX), and pyrimethamine-clindamycin (P-C). A systematic review and meta-analysis were performed to compare the efficacies of these conventional medicines in the treatment. Cohort studies for the treatment of acute T. gondii infection were searched from PubMed, Google Scholar, ect. All the cases number for different group extracted from each included literature were input to meta-analysis 3.13 software to calculate the pooled negative conversion rate (NCR), cure rate (CR) or vertical transmission rate based on their sample size and weight. The pooled NCR with 95% confidence intervals (CI) was used to evaluate the overall rate of a diagnosis positive result conversion to a negative result after treatment, which of spiramycin, azithromycin and TCM were 83.4% (95%CI, 72.1%-90.8%), 82.5% (95%CI, 75.9%-87.6%), and 85.5% (95%CI, 71.3%-93.3%) respectively, with no statistical difference between them. The pooled CR with 95% CI was used to evaluate the overall rate of complete disappearance of clinical symptoms for toxoplasmic encephalitis after therapy, which of P-S, TMP-SMX, and P-C were 49.8% (95%CI, 38. 8% -60.8%), 59.9% (95%CI, 48.9%-70.0%), and 47.6% (95%CI, 24.8%-71.4%) respectively, with no statistical difference between them. Primary T. gondii infection in pregnancy was treated mainly with spiramycin alone or combined with other drugs, and the pooled rate of vertical transmission was about 9.9% (95%CI, 5.9%-16.2%) after therapy. Toxoplasmic encephalitis in AIDS patients was usually treated with sulfonamides combined with other drugs and the pooled CR was 49.4% (95%CI, 37.9%-60.9%). Public Library of Science 2015-09-22 /pmc/articles/PMC4578932/ /pubmed/26394212 http://dx.doi.org/10.1371/journal.pone.0138204 Text en © 2015 Wei et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Wei, Hai-Xia
Wei, Shan-Shan
Lindsay, David S.
Peng, Hong-Juan
A Systematic Review and Meta-Analysis of the Efficacy of Anti-Toxoplasma gondii Medicines in Humans
title A Systematic Review and Meta-Analysis of the Efficacy of Anti-Toxoplasma gondii Medicines in Humans
title_full A Systematic Review and Meta-Analysis of the Efficacy of Anti-Toxoplasma gondii Medicines in Humans
title_fullStr A Systematic Review and Meta-Analysis of the Efficacy of Anti-Toxoplasma gondii Medicines in Humans
title_full_unstemmed A Systematic Review and Meta-Analysis of the Efficacy of Anti-Toxoplasma gondii Medicines in Humans
title_short A Systematic Review and Meta-Analysis of the Efficacy of Anti-Toxoplasma gondii Medicines in Humans
title_sort systematic review and meta-analysis of the efficacy of anti-toxoplasma gondii medicines in humans
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4578932/
https://www.ncbi.nlm.nih.gov/pubmed/26394212
http://dx.doi.org/10.1371/journal.pone.0138204
work_keys_str_mv AT weihaixia asystematicreviewandmetaanalysisoftheefficacyofantitoxoplasmagondiimedicinesinhumans
AT weishanshan asystematicreviewandmetaanalysisoftheefficacyofantitoxoplasmagondiimedicinesinhumans
AT lindsaydavids asystematicreviewandmetaanalysisoftheefficacyofantitoxoplasmagondiimedicinesinhumans
AT penghongjuan asystematicreviewandmetaanalysisoftheefficacyofantitoxoplasmagondiimedicinesinhumans
AT weihaixia systematicreviewandmetaanalysisoftheefficacyofantitoxoplasmagondiimedicinesinhumans
AT weishanshan systematicreviewandmetaanalysisoftheefficacyofantitoxoplasmagondiimedicinesinhumans
AT lindsaydavids systematicreviewandmetaanalysisoftheefficacyofantitoxoplasmagondiimedicinesinhumans
AT penghongjuan systematicreviewandmetaanalysisoftheefficacyofantitoxoplasmagondiimedicinesinhumans